Fig. 5From: Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implicationsResponse operating characteristic (ROC) curves for prediction of LN metastasis using galectins, CA 125 or CA 19.9Back to article page